Efficacy and safety of high-dose chemotherapy as second or subsequent salvage therapy in relapsed or refractory germ cell cancer patients: A multicentric analysis

被引：0
|
作者：
Seidel, C. [1 ]
De Giorgi, U. F. F. [2 ]
Engel, N. [1 ]
Hentrich, M. [3 ]
Zschaebitz, S. [4 ]
Conolly, E. [5 ]
Weickhardt, A. J. [6 ]
Grimison, P. [7 ]
Wong, V. [8 ]
Oing, C. [9 ]
Alsdorf, W. [1 ]
Schaefers, C. [1 ]
Bokemeyer, C. [1 ]
Tran, B. [10 ]
机构：
[1] UKE Univ Klinikum Hamburg Eppendorf KMTZ, Oncol Hematol & Bone Marrow Transplantat, Hamburg, Germany
[2] IRST Ist Romagnolo Studio Tumori Dino Amadori IRC, Med Oncol Dept, Meldola, Italy
[3] Rotkreuzklinikum Munchen, Dept Hematol & Oncol, Munich, Germany
[4] NCT Nationales Zentrum Tumorerkrankungen, Med Oncol Dept, Heidelberg, Germany
[5] Chris OBrien Lifehouse, Oncol, Sydney, NSW, Australia
[6] Olivia Newton John Canc Wellness & Res Ctr, Med Oncol Dept, Heidelberg, Vic, Australia
[7] Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia
[8] WEHI Walter & Eliza Hall Inst Med Res, Oncol, Parkville, Vic, Australia
[9] Newcastle Univ, Sir Bobby Robson Clin Trials Res Ctr, Newcastle Upon Tyne, England
[10] Peter MacCallum Canc Ctr, Med Oncol Dept, Melbourne, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.678
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
732P
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [31] High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy
    SI Bearman
    JJ Vredenburgh
    PJ Cagnoni
    EJ Shpall
    Y Nieto
    M Ross
    WP Peters
    RB Jones
    Bone Marrow Transplantation, 1999, 24 : 491 - 495
  • [32] High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy
    Bearman, SI
    Vredenburh, JJ
    Cagnoni, PJ
    Shpall, EJ
    Nieto, Y
    Ross, M
    Peters, WP
    Jones, RB
    BONE MARROW TRANSPLANTATION, 1999, 24 (05) : 491 - 495
  • [33] Salvage treatment for germ cell cancer after failed high-dose therapy
    Shamash, J
    Asterling, S
    Oliver, RTD
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 787 - 788
  • [34] High-dose chemotherapy in germ-cell cancer salvage regimens: where next?
    R Tim D Oliver
    Nature Clinical Practice Urology, 2005, 2 : 590 - 591
  • [35] High-dose chemotherapy in germ-cell cancer salvage regimens: where next?
    Oliver, RTD
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (12): : 590 - 591
  • [36] High-dose chemotherapy and auto-SCT for relapsed and refractory Hodgkin's lymphoma patients refractory to first-line salvage chemotherapy but responsive to second-line salvage chemotherapy
    Rauf, Muhammad Shahzad
    Maghfoor, Irfan
    Elhassan, Tusneem Ahmed M.
    Akhtar, Saad
    MEDICAL ONCOLOGY, 2015, 32 (01)
  • [37] High-dose chemotherapy and auto-SCT for relapsed and refractory Hodgkin’s lymphoma patients refractory to first-line salvage chemotherapy but responsive to second-line salvage chemotherapy
    Muhammad Shahzad Rauf
    Irfan Maghfoor
    Tusneem Ahmed M. Elhassan
    Saad Akhtar
    Medical Oncology, 2015, 32
  • [38] Sequential high-dose chemotherapy (HDCT) for relapsed or refractory germ cell cancer (rGCC): Results of a unicentric standardized approach
    Niegisch, Guenter
    Henn, Alina
    Zaum, Martin
    Kobbe, Guido
    Haas, Rainer
    Schirren, Joachim
    Albers, Peter
    Lorch, Anja
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma
    Gururangan, Srldharan
    Krauser, Jeanne
    Watral, Melody A.
    Driscoll, Tim
    Larrier, Nicole
    Reardon, David A.
    Rich, Jeremy N.
    Quinn, Jennifer A.
    Vreclenburgh, James J.
    Desjardins, Annick
    McLendon, Roger E.
    Fuchs, Herbert
    Kurtzberg, Joanne
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2008, 10 (05) : 745 - 751
  • [40] High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours
    El-Helw, Loale M.
    Naik, Jay D.
    Chester, John D.
    Joffe, Johnathan K.
    Selby, Peter J.
    Coleman, Robert E.
    BJU INTERNATIONAL, 2006, 98 (03) : 519 - 525
12345